Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Nano-X Imaging Ltd.NNOX · Entity 7098 | Chief Financial Officer | October 14, 2026 | October 14, 2026 |
| Valens Semiconductor Ltd.VLN · Entity 6383 | CFO | March 18, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Nano-X Imaging Ltd.
Report date October 14, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 50,000 |
Reported balance
After 2026-10-14 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2026-10-14 · Grant · Acquired 50,000 · Balance 50,000 F1: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 50,000 ordinary shares represented by 50,000 restricted share units ("RSUs") pursuant to the Issuer's 2019 Equity Incentive Plan. F2: Of the 50,000 RSUs representing 50,000 ordinary shares that are reflected in this row, 50% (25,000) vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (October 14, 2027) and the remaining 50% (25,000) vest and settle for underlying ordinary shares on the 24-month anniversary of the grant date (October 14, 2028), subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2026-10-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 50,000 F3: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only. F4: Of the 50,000 RSUs representing 50,000 ordinary shares that are reflected in this row, which were granted to the Reporting Person by the Issuer on July 15, 2026, 50% (25,000) vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (July 15, 2027) and the remaining 50% (25,000) vest and settle for underlying ordinary shares on the 24-month anniversary of the grant date (July 15, 2028), subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 50,000 ordinary shares represented by 50,000 restricted share units ("RSUs") pursuant to the Issuer's 2019 Equity Incentive Plan.
F2: Of the 50,000 RSUs representing 50,000 ordinary shares that are reflected in this row, 50% (25,000) vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (October 14, 2027) and the remaining 50% (25,000) vest and settle for underlying ordinary shares on the 24-month anniversary of the grant date (October 14, 2028), subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date.
F3: There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F4: Of the 50,000 RSUs representing 50,000 ordinary shares that are reflected in this row, which were granted to the Reporting Person by the Issuer on July 15, 2026, 50% (25,000) vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (July 15, 2027) and the remaining 50% (25,000) vest and settle for underlying ordinary shares on the 24-month anniversary of the grant date (July 15, 2028), subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date.
Valens Semiconductor Ltd.
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 155,000 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 155,000 F1: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (02/01/2025) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 105,000 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 105,000 F2: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (01/23/2026) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 105,000 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 105,000 F3: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (02/24/2027) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.27 · Expires 2032-06-26 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F4: The Options vest in full on the second year anniversary of the grant (06/26/2027), subject to the Reporting Person's continued service to the Company or its subsidiaries on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (02/01/2025) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
F2: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (01/23/2026) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
F3: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (02/24/2027) and the reamining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.
F4: The Options vest in full on the second year anniversary of the grant (06/26/2027), subject to the Reporting Person's continued service to the Company or its subsidiaries on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 14, 2026 Filed Oct 14, 2026 20:05 UTC | Nano-X Imaging Ltd. NNOX · Entity 7098 | GrantOrdinary Shares | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-109420 · ownership.xml · nonDerivative · entry 1 Nathansohn Guy · CIK 0002086498 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · kind: The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 50,000 ordinary shares represented by 50,000 restricted share units ("RSUs") pursuant to the Issuer's 2019 Equity Incentive Plan. F2 · balance_after: Of the 50,000 RSUs representing 50,000 ordinary shares that are reflected in this row, 50% (25,000) vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (October 14, 2027) and the remaining 50% (25,000) vest and settle for underlying ordinary shares on the 24-month anniversary of the grant date (October 14, 2028), subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.